Clinical Trial Update: Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on using eculizumab to prevent and treat kidney graft reperfusion injury in patients with end-stage renal disease or kidney failur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Graft Reperfusion Injury
• Kidney Failure

Drugs mentioned

• Eculizumab (eculizumab)

Snippet

Sponsor: Russian Academy of Medical Sciences | Conditions: End-Stage Renal Disease, Kidney Failure | Phase 2 | Status: COMPLETED